EP 1284961 A1 20030226 - GLYCINAMIDES
Title (en)
GLYCINAMIDES
Title (de)
GLYCINAMIDE
Title (fr)
GLYCINAMIDES
Publication
Application
Priority
- DE 10027025 A 20000531
- EP 0104110 W 20010410
Abstract (en)
[origin: WO0192219A1] Novel compounds of formula (I), wherein R, R<1> and R<2> have the meanings given in patent claim no.1, are inhibitors of the coagulation factor Xa and can be used for the prevention and/or therapy of thromboembolic diseases.
IPC 1-7
C07C 311/39; C07C 317/32; C07D 211/46; C07D 213/30; C07D 257/04; C07D 271/06; C07D 413/12; A61K 31/167; A61P 7/02
IPC 8 full level
A61K 31/167 (2006.01); A61K 31/18 (2006.01); A61K 31/22 (2006.01); A61K 31/223 (2006.01); A61K 31/27 (2006.01); A61K 31/41 (2006.01); A61K 31/4245 (2006.01); A61K 31/4402 (2006.01); A61K 31/445 (2006.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); A61P 29/00 (2006.01); C07C 311/39 (2006.01); C07C 317/22 (2006.01); C07C 317/32 (2006.01); C07C 381/00 (2006.01); C07D 211/46 (2006.01); C07D 213/30 (2006.01); C07D 257/04 (2006.01); C07D 271/06 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP US)
A61P 7/02 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 29/00 (2017.12 - EP); C07C 311/39 (2013.01 - EP US); C07C 317/32 (2013.01 - EP US); C07D 211/46 (2013.01 - EP US); C07D 213/30 (2013.01 - EP US); C07D 257/04 (2013.01 - EP US); C07D 271/06 (2013.01 - EP US); C07D 413/12 (2013.01 - EP US)
Citation (search report)
See references of WO 0192219A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0192219 A1 20011206; AU 6019201 A 20011211; CA 2410627 A1 20021128; DE 10027025 A1 20011206; EP 1284961 A1 20030226; JP 2003535075 A 20031125; US 2003166694 A1 20030904
DOCDB simple family (application)
EP 0104110 W 20010410; AU 6019201 A 20010410; CA 2410627 A 20010410; DE 10027025 A 20000531; EP 01933811 A 20010410; JP 2002500834 A 20010410; US 29675102 A 20021127